More than 20 years since the WHO published its three-step guideline for controlling cancer pain, European patients are still complaining of pain that is long lasting, interferes with their daily activities and can even be [more]
Chemobrain’ is an informal term coined by patients who are or were on chemotherapy, to express the feeling of being not quite switched on or able to think clearly and focus on the [more]
Images of gaunt, wasted bodies are shocking and often linked to feelings of shame, blame or guilt. When patients with advanced cancer begin to look this way, the problem lies with the cancer more than [more]
The genomic era offers enormous potential for patients with rare cancers, but progress is being held back by structures that separate research from care, regulatory practices that penalise small patient populations, and rules that restrict [more]
Ambulatory care services are coming under huge pressure from the steady rise in the number of cancer patients who require long-term follow-up. Facilities are overcrowded, staff overstretched, and extended clinic waiting times are becoming the [more]
Emiel Rutgers was ‘tailoring’ his therapies long before the term was popularised. He pioneered breast conservation and neo-adjuvant chemotherapy in the Netherlands against opposition, but was also an advocate, just as controversially, of complete mastectomy [more]
New oncoplastic techniques are revolutionising the surgical management of breast cancer in much the same way that breast conserving surgery did in the 1970s. These technically demanding procedures are used as alternatives to mastectomy in [more]
If caught early, only the most aggressive breast cancers require any treatment beyond surgery, says László Tabár. He wants governments to provide effective population screening from the age of 40, and he would like medical [more]
A variety of factors are now known to contribute to raising women’s risk of developing breast cancer. Ensuring key messages on breast health become as familiar as themessage Smoking is bad for your health’may [more]
In patients with advanced hepatocellular carcinoma who have a good performance status and ChildTurcottePugh class A liver function, sorafenib represents a new standard of care. Download full article
A recent study showed no benefit from extending lymphadenectomy beyond D1+ in gastric cancer. Adequate lymphadenectomy at high-volume institutions is essential for locoregional control and survival in this group of patients. Download full article
Selected reports edited by Janet Fricker Download full article
Politically correct wording seems to be a must, and in many areas this leads to variously differing solutions, which can all be criticised. But a fact is a fact, and hiding it behind nicer’ words [more]